Gastric bypass and banding equally improve insulin sensitivity and β cell function.

Bariatric surgery in obese patients is a highly effective method of preventing or resolving type 2 diabetes mellitus (T2DM); however, the remission rate is not the same among different surgical procedures. We compared the effects of 20% weight loss induced by laparoscopic adjustable gastric banding (LAGB) or Roux-en-Y gastric bypass (RYGB) surgery on the metabolic response to a mixed meal, insulin sensitivity, and β cell function in nondiabetic obese adults. The metabolic response to meal ingestion was markedly different after RYGB than after LAGB surgery, manifested by rapid delivery of ingested glucose into the systemic circulation, by an increase in the dynamic insulin secretion rate, and by large, early postprandial increases in plasma glucose, insulin, and glucagon-like peptide-1 concentrations in the RYGB group. However, the improvement in oral glucose tolerance, insulin sensitivity, and overall β cell function after weight loss were not different between surgical groups. Additionally, both surgical procedures resulted in a similar decrease in adipose tissue markers of inflammation. We conclude that marked weight loss itself is primarily responsible for the therapeutic effects of RYGB and LAGB on insulin sensitivity, β cell function, and oral glucose tolerance in nondiabetic obese adults.

[1]  S. Klein,et al.  Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects. , 2012, Gastroenterology.

[2]  S. Klein,et al.  Multiorgan Insulin Sensitivity in Lean and Obese Subjects , 2012, Diabetes Care.

[3]  Yaniv Harel,et al.  Accelerated Gastric Emptying but No Carbohydrate Malabsorption 1 Year After Gastric Bypass Surgery (GBP) , 2012, Obesity Surgery.

[4]  G. Shulman,et al.  Mechanisms for Insulin Resistance: Common Threads and Missing Links , 2012, Cell.

[5]  S. Summers,et al.  Ceramides as modulators of cellular and whole-body metabolism. , 2011, The Journal of clinical investigation.

[6]  A. Chawla,et al.  Macrophage-mediated inflammation in metabolic disease , 2011, Nature Reviews Immunology.

[7]  D. D’Alessio,et al.  Gastric Bypass Surgery Enhances Glucagon-Like Peptide 1–Stimulated Postprandial Insulin Secretion in Humans , 2011, Diabetes.

[8]  R. Murphy,et al.  Analysis of Diacylglycerol Molecular Species in Cellular Lipid Extracts by Normal-Phase LC-Electrospray Mass Spectrometry. , 2011, International journal of mass spectrometry.

[9]  J. Varela.  Bariatric surgery: a cure for diabetes? , 2011, Current opinion in clinical nutrition and metabolic care.

[10]  Tadao Shibasaki,et al.  Dynamics of insulin secretion and the clinical implications for obesity and diabetes. , 2011, The Journal of clinical investigation.

[11]  K. Eckardt,et al.  Obesity-associated insulin resistance in skeletal muscle: Role of lipid accumulation and physical inactivity , 2011, Reviews in Endocrine and Metabolic Disorders.

[12]  S. Kahn,et al.  Acute effect of roux-en-y gastric bypass on whole-body insulin sensitivity: a study with the euglycemic-hyperinsulinemic clamp. , 2010, The Journal of clinical endocrinology and metabolism.

[13]  G. Shulman,et al.  The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome. , 2010, Annual review of nutrition.

[14]  K. Petersen,et al.  Lipid-induced insulin resistance: unravelling the mechanism , 2010, The Lancet.

[15]  Yao-min Hu,et al.  Postchallenge plasma glucose excursions, carotid intima-media thickness, and risk factors for atherosclerosis in Chinese population with type 2 diabetes. , 2010, Atherosclerosis.

[16]  J. Teixeira,et al.  Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery , 2010, Journal of diabetes.

[17]  P. Schauer,et al.  Acute effects of gastric bypass versus gastric restrictive surgery on β-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes , 2010, International Journal of Obesity.

[18]  N. Basso,et al.  Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes , 2010, Surgical Endoscopy.

[19]  M. Schambelan,et al.  Improvement in Peripheral Glucose Uptake After Gastric Bypass Surgery Is Observed Only After Substantial Weight Loss Has Occurred and Correlates with the Magnitude of Weight Lost , 2009, Journal of Gastrointestinal Surgery.

[20]  B. S. Mohammed,et al.  Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity , 2009, Proceedings of the National Academy of Sciences.

[21]  B. S. Mohammed,et al.  Weight Loss Reduces Liver Fat and Improves Hepatic and Skeletal Muscle Insulin Sensitivity in Obese Adolescents , 2009, Obesity.

[22]  M. Jensen,et al.  Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. , 2009, The American journal of medicine.

[23]  B. S. Mohammed,et al.  Endoplasmic Reticulum Stress Is Reduced in Tissues of Obese Subjects After Weight Loss , 2009, Diabetes.

[24]  H. Yoshimatsu,et al.  Postchallenge Plasma Glucose and Glycemic Spikes Are Associated with Pulse Pressure in Patients with Impaired Glucose Tolerance and Essential Hypertension , 2008, Hypertension Research.

[25]  K. Polonsky,et al.  Weight Loss Therapy Improves Pancreatic Endocrine Function in Obese Older Adults , 2008, Obesity.

[26]  D. Giugliano,et al.  Post-meal glucose peaks at home associate with carotid intima-media thickness in type 2 diabetes. , 2008, Journal of Clinical Endocrinology and Metabolism.

[27]  N. Nguyen,et al.  Perioperative outcomes of bariatric surgery in adolescents compared with adults at academic medical centers. , 2007, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[28]  Y. Tamura,et al.  Effects of diet-induced moderate weight reduction on intrahepatic and intramyocellular triglycerides and glucose metabolism in obese subjects. , 2007, The Journal of clinical endocrinology and metabolism.

[29]  M. Gross,et al.  Quantification of diacylglycerol molecular species in biological samples by electrospray ionization mass spectrometry after one-step derivatization. , 2007, Analytical chemistry.

[30]  E. Ferrannini,et al.  Effect of Pioglitazone on the Metabolic and Hormonal Response to a Mixed Meal in Type II Diabetes , 2007, Clinical pharmacology and therapeutics.

[31]  S. Klein,et al.  Assessment of intrahepatic triglyceride content using magnetic resonance spectroscopy. , 2007, Journal of the cardiometabolic syndrome.

[32]  R. Wadwa,et al.  Beta-cell function, insulin sensitivity, and glucose tolerance in obese diabetic and nondiabetic adolescents and young adults. , 2006, The Journal of clinical endocrinology and metabolism.

[33]  R. Wadwa,et al.  β-Cell Function, Insulin Sensitivity, and Glucose Tolerance in Obese Diabetic and Nondiabetic Adolescents and Young Adults , 2006 .

[34]  K. Petersen,et al.  Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. , 2005, Diabetes.

[35]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[36]  L. Kuller,et al.  Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes Mellitus , 2003, Annals of surgery.

[37]  B. Ahrén,et al.  Improved beta-cell function after standardized weight reduction in severely obese subjects. , 2003, American journal of physiology. Endocrinology and metabolism.

[38]  Xianlin Han,et al.  Characterization and direct quantitation of ceramide molecular species from lipid extracts of biological samples by electrospray ionization tandem mass spectrometry. , 2002, Analytical biochemistry.

[39]  Claudio Cobelli,et al.  Insulin release in impaired glucose tolerance: oral minimal model predicts normal sensitivity to glucose but defective response times. , 2002, Diabetes.

[40]  R. Bergman,et al.  Accurate Assessment of β-Cell Function: The Hyperbolic Correction , 2002 .

[41]  M. Hanefeld,et al.  Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. , 2000, Diabetes care.

[42]  L. Niskanen,et al.  The effects of weight loss on insulin sensitivity, skeletal muscle composition and capillary density in obese non-diabetic subjects. , 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[43]  M M Tai,et al.  A Mathematical Model for the Determination of Total Area Under Glucose Tolerance and Other Metabolic Curves , 1994, Diabetes Care.

[44]  R. Steele,et al.  INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT * , 1959, Annals of the New York Academy of Sciences.